Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly

BACKGROUND: The long-acting somatostatin analogue octreotide is used either as an adjuvant or primary therapy to lower growth hormone (GH) levels in patients with acromegaly and may also induce pituitary tumor shrinkage. OBJECTIVE: We performed a meta-analysis to accurately assess the effect of octr...

Descripción completa

Detalles Bibliográficos
Autores principales: Giustina, Andrea, Mazziotti, Gherardo, Torri, Valter, Spinello, Maurizio, Floriani, Irene, Melmed, Shlomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344864/
https://www.ncbi.nlm.nih.gov/pubmed/22574156
http://dx.doi.org/10.1371/journal.pone.0036411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344864/
https://www.ncbi.nlm.nih.gov/pubmed/22574156
http://dx.doi.org/10.1371/journal.pone.0036411

Ejemplares similares